Will FDA Approve Genetically Modified Salmon?

The Food and Drug Administration could approve genetically modified salmon for human consumption. Anne Kapuscinski, professor of Sustainability Science at Dartmouth College, offers her insight.

MELISSA BLOCK, Host:

So what should we know about this fish and its future? Professor Anne Kapuscinski is a fisheries biologist at Dartmouth College. She has studied both endangered salmon and genetically modified fish. Welcome to the program.

P: Thank you for having me.

BLOCK: And why don't you explain first how this salmon has been genetically modified to grow faster?

P: In the case of these salmon, they've just taken the part of the DNA that acts like a switch, and that switch turns on the gene that produces the growth hormone so that the salmon will produce growth hormone in its tissues throughout the year, whereas a conventional salmon only produces growth hormone during the warmer times of the year, when the water temperatures are warmer.

BLOCK: So they end up growing to market size in - what, 18 months instead of three years.

P: I think that's about right. It's about half the time.

BLOCK: When the FDA studies this genetically modified salmon to see whether it's safe to eat, what are they looking at? How do they make that decision?

P: They are not required to conclude that they're environmentally safe, and that's the only condition under which to approve them. That law just requires an environmental assessment, basically figuring out what would be the effect on the quality of the human environment.

BLOCK: And you're saying they're asking the company for that data. This is information coming directly from the company that's producing the fish?

P: So the company runs whatever tests they think are appropriate. That's done in consultation with the FDA. They produce the data, and then report that data to the FDA. The FDA has its own staff of scientists that then evaluate the data.

BLOCK: And as a scientist yourself who studies these organisms, how do you feel about that system and the transparency of that?

P: I would like to see a much more transparent system. It's fine for the company to do the test. One could argue that you should place the burden on them because they're the ones who might profit. They, therefore, should be the ones who would spend the money to do the tests. But it would be much better if the data were all publicly available, and available for independent scientists to evaluate it.

BLOCK: Let's say the salmon is approved and does reach market. What about labeling? Would a consumer know that this is a genetically modified fish?

P: So if they don't require labeling, consumers would only know if the company decides, on its own, to voluntarily label the fish.

BLOCK: Well, Professor Kapuscinski, thanks for talking with us.

P: Thank you very much for having me.

BLOCK: That's Anne Kapuscinski, professor of sustainability science at Dartmouth College. She was talking with us about the possibility that the FDA will approve the first genetically modified animal for human consumption: a salmon.

Copyright © 2010 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.